WORK PLAN FOR BILATERAL COOPERATION IN 2017-2019
WORK PLAN FOR BILATERAL COOPERATION IN 2017-2019 BETWEEN THE NATIONAL COMMITTEE FOR INTELLECTUAL PROPERTY RIGHTS (NCIPR)/MINISTRY OF COMMERCE (MOC) OF THE KINGDOM OF CAMBODIA AND THE STATE INTELLECTUAL PROPERTY OFFICE OF THE PEOPLES REPUBLIC OF CHINA On August 17, 2017 [1] the Intellectual Property Office of the Kingdom of Cambodia, on its online portal, released […]
Patent Registration Process under Patent Cooperation Treaty (PCT)
With a massive increase in the filing of international applications, clients have been constantly asking queries pertaining to the patent registration process under Patent Cooperation Treaty (PCT). This article is a quick reference for an overview of the procedure for filing a patent application under the PCT route. For filing a patent application in several countries an […]
Foreign Filing License Requirement
At various instances, an applicant or an inventor may require to file a patent application directly in a foreign country other than country of residence. There could be diverse reasons pertaining first filing in a foreign country, such as, non-patentable subject matter in country of residence, low market potential in country of residence, etc. In […]
Enzo Biochem Inc. v. Applera Corp. – A case pertaining to Doctrine of Equivalents
On August 02, 2017, the United States Court of Appealsfor the Federal Circuit ruled in favor of Applera Corp.and Tropix Inc.in the matter of Enzo Biochem Inc., Enzo Life Sciences Inc., Yale University v. Applera Corp., Tropix Inc. The Court affirmed that the district court accurately interpreted proper construction of claims in U.S. Patent No.5,449,767 (“the’767 patent”) and correctly […]
United States district court upholds the validity of two Horizon Pharma patents covering VIMOVO®
Horizon Pharma plc, an Irish specialty biopharmaceutical company, on 27 June 2017, reported that the United States district court for the district of New Jersey upheld the validity of two Horizon Pharma patents covering VIMOVO®, a pain relief treatment for arthritis patients, and that the ANDA applicants viz. Lupin Limited, Dr. Reddy’s Laboratories and Mylan […]
TAKEDA PHARMACEUTICAL’S PATENT ON CANCER DRUG VELCADE® UPHELD BY THE US COURT OF APPEALS FOR THE FEDERAL CIRCUIT
On July 17, 2017, the United States Court of Appeals for the Federal Circuit ruled that the U.S. Patent No. 6,713,446 (“the ‘446 patent”) covering Takeda Pharmaceutical’s cancer drug Velcade® is valid and enforceable. The appellate court decision overturned an earlier 2015 decision from a US District Court which ruled the ‘446 patent was invalid […]
GST Implication on Intellectual Property
GST IMPLICATION ON INTELLECTUAL PROPERTY Once upon a time . . . Before the Goods and Services Tax (GST) regime,the Union government exclusively used to levy tax on transactions relating to Intellectual Property (IP) rights if such were classified as services[1] (under Service Tax, Chapter V, Finance Act, 1994), while the State governments used to levy tax on […]
The Exclusivity of Brand Taglines
Brand taglines are catch phrases which serve to draw a connection for consumers with the business’ products and services, and the concerned brand in general. A particular sequence of words repetitively used in the promotion of a brand or business in relation to its products and services often finds a place in the associative memory […]
Revolutionizing Gesture Recognition Technologies: Project Soli
Google has been a pioneer of a number of leading inventions and projects that have not only changed the way we perceive science and technology but has also made out lives easier and leisurelier. From Google Cardboard to Driverless cars to Google glasses, Google has never disappointed us when it comes to show casing its talent in the world of technology […]
Revised Guidelines for Examination of Computer-related Inventions (CRIs)
On 30th June 2017, the Office of the Controller General of Patents, Designs, and Trade Marks (CGPDTM) published Revised Guidelines for Examination of Computer-related Inventions (CRIs) that are applicable with immediate effect. The revised guidelines have replaced the Guidelines for Examination of CRIs, published on 19th February, 2016. The revised guidelines are short and precise as […]